News & Updates

Show Multimedia Only

What is the most preferred first-line agent for paediatric alopecia areata?

25 May 2022 by

In the treatment of paediatric alopecia areata (AA), an autoimmune, nonscarring hair loss disorder with a variable disease course and significant psychosocial impact, the most preferred first-line agent is topical corticosteroids, followed by contact immunotherapy, according to a study.

25 May 2022

Long, irregular menstrual cycles up NAFLD risk

25 May 2022

Young, premenopausal women with long or irregular menstrual cycles are at an increased risk of both prevalent and incident nonalcoholic fatty liver disease (NAFLD), reveals a study.

25 May 2022

Preop radiotherapy, immediate reconstruction feasible in breast cancer patients

25 May 2022 by

Preoperative radiotherapy (preop RT), followed by skin-sparing mastectomy and immediate deep inferior epigastric perforator (DIEP) flap reconstruction, is technically feasible and safe in breast cancer patients who require mastectomy, the PRADA* trial suggests.

25 May 2022

Headband device feasible, acceptable for sleep measurements in chronic pain patients

25 May 2022 by

People suffering from chronic pain find the Dreem 2, a novel headband-type wearable device, satisfactory for the measurement of sleep parameters, according to a recent study.

25 May 2022

Continued ICS treatment for COPD may not be appropriate for patients with high eosinophil count

25 May 2022

The overall effect of continued use of inhaled corticosteroid (ICS) in patients with chronic obstructive pulmonary disease (COPD) appears to increase commensurate with the blood eosinophil count, a study has found.

25 May 2022

Prenatal Zika delays neurodevelopment in kids

25 May 2022

Infants of mothers with Zika virus infection suffer from various neurodevelopmental sequelae during childhood, particularly in terms of language, a new study reveals.

25 May 2022

Oral potassium supplementation to correct hypokalaemia lowers peritonitis risk in patients on PD

25 May 2022

Maintaining serum potassium concentration in the range of 4–5 mEq/L with protocol-based oral potassium treatment appears to protect against peritonitis in patients who are receiving peritoneal dialysis (PD) and have hypokalaemia, according to a study.

25 May 2022

Onasemnogene abeparvovec for spinal muscular atrophy safe in heavier babies

24 May 2022

Babies who weigh ≥8.5 kg can safely be administered with onasemnogene abeparvovec for the treatment of spinal muscular atrophy, a new study has found.

24 May 2022

Cranberries sharpen memory, neural function in healthy seniors

24 May 2022 by

Eating a small cup of cranberries daily is apparently good for the brain, enhancing memory consolidation and retrieval for everyday events as well as neural functioning in healthy older adults, as shown in a recent study.

24 May 2022

Hypothyroidism, lower FT4 levels tied to greater T2D risk

24 May 2022

People with hypothyroidism and lower free thyroxine (FT4) levels in the reference range have a higher risk of type 2 diabetes (T2D), suggests a recent study.

24 May 2022

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

What is the most preferred first-line agent for paediatric alopecia areata?

Long, irregular menstrual cycles up NAFLD risk

Preop radiotherapy, immediate reconstruction feasible in breast cancer patients

Headband device feasible, acceptable for sleep measurements in chronic pain patients

Continued ICS treatment for COPD may not be appropriate for patients with high eosinophil count

Prenatal Zika delays neurodevelopment in kids

Oral potassium supplementation to correct hypokalaemia lowers peritonitis risk in patients on PD

Onasemnogene abeparvovec for spinal muscular atrophy safe in heavier babies

Cranberries sharpen memory, neural function in healthy seniors

Hypothyroidism, lower FT4 levels tied to greater T2D risk